European Commission approves use of Ameluz® for the treatment of actinic keratosis on extremities and trunk/neck
March 10, 2020 11:00 ET
|
Biofrontera AG
Leverkusen, Germany, March 10, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced that...